TITLE

Keeping Pace

AUTHOR(S)
Gray, Nicole
PUB. DATE
July 2006
SOURCE
European Pharmaceutical Executive;Jul/Aug2006, p38
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article provides information on the developments related to pharmaceutical companies in 2005. There were 17 new products out in the market, the number of consolidations increased, and biologics grew faster than the overall market. In addition, generic prescriptions increased by 13% and $17 billion worth of products have lost their patents, including Duragesic, Allegra and Rocephin.
ACCESSION #
23932274

 

Related Articles

  • INDIAN SCENE.  // Chemical Business;Dec2001, Vol. 15 Issue 12, p43 

    Presents news briefs on the chemical and pharmaceutical industries in India as of December 2001. Concerns of the pharmaceutical industry regarding the compulsory licensing rule of the World Trade Organization; Expected growth in generic drugs export; Merger between CHEMB.Com and ChemXL;...

  • Research & Markets: Drug Patent Review and Outlook 2010.  // Biomedical Market Newsletter;4/14/2011, p139 

    The article reports on the "Drug Patent Review and Outlook 2010" report which is offered by Research & Markets Ltd. It says that companies enter into mergers and acquisitions (M&As), and joint ventures to replace their revenue loss before their patent expires. It also mentions that...

  • Pharma sector to grow at 13%.  // Chemical Business;Mar2007, Vol. 21 Issue 3, p78 

    The article offers information on a study by IndusView on the pharmaceutical industry in India. According to the study, the domestic pharmaceutical industry is expected to grow 13% and reach a market size of $6.5 billion. Topics discussed include low cost, high volume generic drugs, mergers and...

  • GPhA and NAPM merge as 'one voice'  // Medical Marketing & Media;Mar2001, Vol. 36 Issue 3, p34 

    Reports on the merger between Generic Pharmaceutical Association and the National Association of Pharmaceutical Manufacturers. Purpose of the merger; Plans to raise issues concerning on critical legislative and , regulatory scientific topics; Strategic alliance between Generic Pharmaceutical...

  • Teva Back on Top. Houlton, Sarah // Pharmaceutical Executive;Sep2005, Vol. 25 Issue 9, p28 

    Reports on the acquisition of Ivax by pharmaceutical company Teva in the U.S. Annual sales of the drug manufacturer; Enhancement of the company's leadership in the global generics industry; Expansion of global generic and branded businesses with additional products; Extension of the client base.

  • Mergers & acquisitions (M&A) in the pharmaceutical industry: the wheel keeps on turning. Hornke, Matthias; Mandewirth, Sven // Journal of Business Chemistry;May2010, Vol. 7 Issue 2, p67 

    In this article, the authors discuss mergers and acquisitions (M&A) in the pharmaceutical industry. They note that the global M&A transaction volume fell in 2009, as did the global share of financial investors in purchase volume. They mention that generic drug manufacturers are becoming...

  • Ranbaxy jumps into the global race. Mirasol, Feliza // Chemical Market Reporter;4/10/2006, Vol. 269 Issue 14, p30 

    The article reports on India-based Ranbaxy Pharmaceuticals Inc. is expected to boost its position as a global player with the recent acquisitions of several generic drug firms in Europe. The latest in Ranbaxy's acquisition is Belgium-based Ethimed NV. The deal gives Ranbaxy strategic access to...

  • Consolidation Blurs Drug Categories. AMY REEVES // Investors Business Daily;2/10/2014, pA09 

    Last month, during an otherwise ho-hum conference call on 2014 financial guidance,

  • How Indian companies can become cornerstones in global growth plans. Malik, Rajiv // Pharmaceutical Technology;Sep2007, Vol. 31 Issue 9, p80 

    The article presents a corporate profile of Matrix Laboratories Ltd. in Hyderabad, India. It was acquired by generics company Mylan Laboratories Inc. of Pennsylvania. The acquisition was a landmark deal for the pharmaceutical sector in terms of size and the profiles of both purchaser and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics